Guosen Securities (002736) Earnings Fall 13% in 1H with Net Income at 3.14B Yuan

Guosen Securities on Smartkarma

Analyst coverage on Smartkarma highlights insights on Guosen Securities. Analyst Brian Freitas discusses the upcoming changes to the CSI All Share IB & Brokerage Index. Guosen Securities is set to be added to the index, with expectations for outperformance following this adjustment, while Northeast Securities is to be removed. The announcement of these changes on 31 May will be implemented by 14 June. The analyst points out that there is significant flow and impact on both stocks, creating potential for outperformance or underperformance compared to their peers in the coming weeks.

A look at Guosen Securities Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Guosen Securities Co.,Ltd, a company offering securities services primarily in China, is positioned favorably for long-term growth and stability. Smartkarma Smart Scores indicate a promising outlook for Guosen Securities, with strong ratings in key factors. With high scores in Value and Dividend, the company showcases solid fundamentals and attractive returns for investors. Additionally, a Momentum score of 5 suggests a positive trend in the company’s performance.

While Guosen Securities demonstrates strengths in Value, Dividend, and Momentum, it faces challenges in Resilience and Growth, scoring lower in these areas. Despite this, the overall outlook remains optimistic based on the Smartkarma Smart Scores. Investors looking for a company with a solid financial foundation and growth potential may find Guosen Securities an intriguing opportunity within the securities market.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma